건조 혈액 스팟 채취 카드 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Dried Blood Spot Collection Cards Market size is expected to reach USD 633.49 Million in 2034 from USD 395.63 Million (2025) growing at a CAGR of 5.37% during 2026-2034.

The dried blood spot collection cards market is experiencing significant growth, driven by the increasing demand for convenient and efficient sample collection methods in clinical and research settings. Dried blood spot (DBS) sampling offers several advantages, including ease of use, reduced transportation costs, and the ability to store samples at room temperature. As the focus on point-of-care testing and remote diagnostics grows, the adoption of DBS technology is surging, particularly in applications such as newborn screening, infectious disease testing, and therapeutic drug monitoring.

Moreover, advancements in DBS technology, including the development of novel collection cards and analytical methods, are enhancing the accuracy and reliability of this sampling technique. Innovations in materials and design are improving the stability of samples and facilitating the extraction of analytes, leading to more precise results. The integration of DBS with advanced analytical techniques, such as mass spectrometry and liquid chromatography, is also expanding its applications and driving market growth.

Furthermore, the increasing focus on research and development in the field of diagnostics is fostering innovation in the dried blood spot collection cards market. Collaborations between manufacturers, healthcare providers, and research institutions are driving advancements in DBS technology, ensuring that new products meet the evolving needs of the market. The growing awareness of the benefits of DBS sampling in improving patient compliance and access to testing is also contributing to the expansion of this market.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Application

• New Born Screening (NBS)
• Infectious Diseases Testing
• Therapeutic Drug Monitoring
• Forensics
• CRO/Research
• Other

By Card Type

• Whatman 903
• Ahlstrom 226
• FTA
• Others

By End Use

• Hospitals & Clinics
• Diagnostics centers
• Others

COMPANIES PROFILED

• Hemaxis, Danaher Corporation, Shimadzu, PerkinElmer Inc, QIAGEN, Eastern Business Forms Inc, Ahlstrom, ARCHIMED Life Science GmbH, CENTOGENE NV, Spot On Sciences, Everlywell Inc, Neoteryx, Advance DX

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Application
• 4.2. New Born Screening (NBS) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Infectious Diseases Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Therapeutic Drug Monitoring Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Forensics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. CRO/Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET: BY CARD TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Card Type
• 5.2. Whatman 903 Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Ahlstrom 226 Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. FTA Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET: BY END USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End Use
• 6.2. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Diagnostics centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Application
  • 7.2.2 By Card Type
  • 7.2.3 By End Use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Application
  • 7.3.2 By Card Type
  • 7.3.3 By End Use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Application
  • 7.4.2 By Card Type
  • 7.4.3 By End Use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Application
  • 7.5.2 By Card Type
  • 7.5.3 By End Use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Application
  • 7.6.2 By Card Type
  • 7.6.3 By End Use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL DRIED BLOOD SPOT COLLECTION CARDS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Hemaxis
  • 9.2.2 Danaher Corporation
  • 9.2.3 Shimadzu
  • 9.2.4 PerkinElmer Inc
  • 9.2.5 QIAGEN
  • 9.2.6 Eastern Business Forms Inc
  • 9.2.7 Ahlstrom
  • 9.2.8 ARCHIMED Life Science GmbH
  • 9.2.9 CENTOGENE N.V
  • 9.2.10 Spot On Sciences
  • 9.2.11 Everlywell Inc
  • 9.2.12 Neoteryx
  • 9.2.13 Advance DX